Generation of bispecific antibodies by structure-guided redesign of IgG constant regions. Iwasaki YW, Tharakaraman K, Subramanian V, Khongmanee A, Hatas A, Fleischer E, Rurak TT, Ngok-Ngam P, Tit-Oon P, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R. Front Immunol. 2023 Jan 10;13:1063002.

10 Jan 2023
0
0

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.

Iwasaki YW, Tharakaraman K, Subramanian V, Khongmanee A, Hatas A, Fleischer E, Rurak TT, Ngok-Ngam P, Tit-Oon P, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Front Immunol. 2023 Jan 10;13:1063002.

Tags

Share this

Related Posts

Kanintronkul, Y; Worayuthakarn, R; Thasana, N; Winayanuwattikun, P; Pattanapanyasat, K; Surarit, R; Ruchirawat, S; Svasti, J. Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[a]quinolizin-4-ones. Anticancer Res. 2011, 31, 921–928.
28 Dec 2011
0

Kanintronkul, Y; Worayuthakarn, R; Thasana, N; Winayanuwattikun, P; Pattanapanyasat, K; Surarit, R; Ruchirawat, S; Svasti, J. Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[a]quinolizin-4-ones. Anticancer Res. 2011, 31, 921–928.

Kanintronkul, Y; Worayuthakarn, R; Thasana, N; Winayanuwattikun, P; Pattanapanyasat, K; Surarit, R; Ruchirawat, S; Svasti, J. Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[a]quinolizin-4-ones. Anticancer Res. 2011, 31, 921–928.
View More

Recent Posts